Omaxe (OMAXE)₹100.75−2.72%Residential, Commercial Projects
In the Sep 2026 quarter (consolidated), Omaxe reported sales of ₹575 Cr, up 79.6% from Sep 2025, and net profit of −₹26.06 Cr. For the year to Mar 2026, sales were ₹1,248 Cr and net profit −₹699 Cr.
Company filings, consolidated accounts; latest reported quarter Sep 2026
| Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sep 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 598 | 535 | 341 | 388 | 288 | 540 | 282 | 320 | 301 | 348 | 405 | 575 |
| Expenses | 638 | 683 | 494 | 614 | 417 | 648 | 453 | 490 | 458 | 551 | 400 | 576 |
| Operating Profit | −37.06 | −146 | −151 | −224 | −127 | −106 | −170 | −169 | −155 | −202 | 7.01 | 0.00 |
| OPM % | −6.0% | −27.0% | −44.0% | −58.0% | −44.0% | −20.0% | −60.0% | −53.0% | −51.0% | −58.0% | 1.8% | 0.1% |
| Other Income | 2.99 | 6.99 | 43.91 | 8.99 | 10.99 | 11.98 | 15.97 | 25.95 | 16.96 | 27.96 | 32.96 | 37.95 |
| Interest | 31.96 | 37.91 | 41.93 | 44.91 | 56.94 | 50.94 | 66.90 | 64.91 | 53.92 | 69.91 | 26.95 | 36.95 |
| Depreciation | 14.99 | 14.01 | 6.99 | 7.01 | 10.01 | 12.01 | 6.99 | 8.01 | 8.99 | 9.99 | 8.01 | 9.01 |
| Profit before tax | −82.20 | −192 | −157 | −268 | −183 | −157 | −228 | −217 | −201 | −255 | 5.01 | −7.02 |
| Tax % | −12.0% | −25.1% | −6.0% | −10.0% | −18.0% | −5.0% | −19.1% | −23.1% | −24.1% | −25.0% | 75.0% | 261.0% |
| Net Profit | −72.15 | −144 | −147 | −239 | −150 | −149 | −186 | −166 | −153 | −191 | 1.01 | −26.06 |
| EPS (Rs) | −3.65 | −7.91 | −8.04 | −13.07 | −8.21 | −8.09 | −10.13 | −9.08 | −8.36 | −10.43 | 0.04 | −1.36 |
| Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 1,384 | 1,624 | 1,836 | 1,164 | 1,118 | 475 | 617 | 771 | 1,610 | 1,559 | 1,248 | 1,630 |
| Expenses | 1,146 | 1,345 | 1,582 | 1,039 | 925 | 594 | 666 | 1,079 | 1,962 | 2,174 | 1,949 | 1,984 |
| Operating Profit | 242 | 285 | 260 | 128 | 198 | −119 | −47.07 | −303 | −344 | −609 | −697 | −351 |
| OPM % | 17.0% | 17.0% | 14.0% | 11.0% | 18.0% | −25.0% | −8.0% | −39.0% | −21.0% | −39.0% | −56.0% | −21.5% |
| Other Income | 53.87 | 58.93 | 58.90 | 33.95 | 27.97 | 38.92 | 19.97 | 24.95 | 20.97 | 75.88 | 85.86 | 116 |
| Interest | 147 | 155 | 169 | 73.83 | 108 | 161 | 121 | 113 | 130 | 195 | 255 | 188 |
| Depreciation | 9.99 | 9.01 | 8.99 | 8.99 | 73.03 | 63.01 | 46.98 | 64.99 | 54.03 | 37.01 | 34.98 | 36.00 |
| Profit before tax | 139 | 179 | 141 | 79.19 | 44.12 | −306 | −194 | −458 | −509 | −766 | −901 | −458 |
| Tax % | 45.0% | 41.0% | 39.0% | 37.9% | 319.0% | −23.1% | −17.0% | −23.0% | −20.1% | −10.0% | −22.0% | — |
| Exceptional items | 0.00 | 0.00 | 0.00 | 0.99 | 12.98 | 0.99 | 3.99 | 0.99 | 0.99 | 11.99 | 13.98 | — |
| Net Profit | 77.12 | 105 | 85.09 | 49.07 | −97.17 | −235 | −162 | −351 | −407 | −687 | −699 | −370 |
| EPS (Rs) | 4.19 | 5.56 | 4.58 | 2.67 | −5.31 | −12.84 | −8.69 | −18.98 | −21.95 | −37.43 | −37.98 | −20.11 |
| Dividend payout % | 17.0% | 13.0% | 15.0% | 25.9% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | — |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 | 183 |
| Reserves | 1,802 | 1,855 | 1,945 | 2,021 | 1,564 | 1,461 | 1,228 | 1,066 | 718 | 299 | −390 | −1,089 |
| Borrowings | 1,343 | 1,326 | 1,501 | 1,800 | 1,853 | 1,668 | 1,527 | 1,125 | 1,106 | 795 | 795 | 1,464 |
| Other Liabilities | 3,579 | 4,351 | 4,691 | 4,123 | 7,157 | 7,234 | 8,102 | 9,543 | 11,546 | 12,540 | 14,278 | 15,955 |
| Total Liabilities | 6,907 | 7,715 | 8,320 | 8,128 | 10,758 | 10,545 | 11,039 | 11,918 | 13,554 | 13,816 | 14,866 | 16,512 |
| Fixed Assets | 118 | 597 | 602 | 602 | 597 | 745 | 668 | 625 | 580 | 563 | 604 | 169 |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 19.92 | 21.92 | 11.97 | 11.96 | 11.95 | 11.96 | 11.97 | 12.96 | 13.96 | 28.91 | 20.92 | 17.94 |
| Other Assets | 6,769 | 7,097 | 7,706 | 7,514 | 10,149 | 9,787 | 10,359 | 11,280 | 12,960 | 13,224 | 14,242 | 16,325 |
| Inventories | 4,469 | 4,510 | 4,866 | 5,117 | 8,394 | 8,219 | 8,579 | 9,261 | 10,422 | 10,498 | 10,979 | 12,301 |
| Trade receivables | 769 | 788 | 1,046 | 792 | 351 | 341 | 387 | 383 | 384 | 357 | 309 | 262 |
| Cash & equivalents | 240 | 260 | 223 | 262 | 242 | 202 | 275 | 300 | 492 | 538 | 742 | 906 |
| Total Assets | 6,907 | 7,715 | 8,320 | 8,128 | 10,758 | 10,545 | 11,039 | 11,918 | 13,554 | 13,816 | 14,866 | 16,512 |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash from operating activity | 362 | 91.08 | 121 | 19.01 | 400 | 638 | 566 | 784 | 469 | 987 | 1,008 | 212 |
| Cash from investing activity | −6.01 | 6.01 | 20.04 | 21.02 | 16.02 | 106 | 23.02 | −22.02 | −142 | −64.05 | −126 | 60.13 |
| Cash from financing activity | −392 | −105 | −173 | −35.03 | −436 | −784 | −518 | −742 | −263 | −926 | −772 | −82.17 |
| Net cash flow | −34.10 | −7.02 | −32.12 | 4.01 | −18.04 | −39.09 | 72.16 | 21.06 | 65.19 | −1.01 | 111 | 190 |
| Capex | 10.08 | 15.71 | 19.80 | 15.73 | 14.90 | 9.73 | 7.44 | 17.14 | 20.42 | 16.83 | 24.04 | 29.52 |
| Free cash flow | 351 | 75.78 | 102 | 4.99 | 392 | 634 | 568 | 779 | 457 | 982 | 997 | 185 |
| CFO / OP % | 169.9% | 54.0% | 57.9% | 20.9% | 335.9% | 331.9% | −468.1% | −1,695.1% | −149.1% | −290.1% | −174.1% | −38.1% |
| Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor days | 199 | 208 | 235 | 158 | 110 | 111 | 298 | 227 | 182 | 81 | 73 | 77 |
| Inventory days | — | — | — | — | — | — | — | — | — | 16,214 | — | — |
| Days payable | — | — | — | — | — | — | — | — | — | 1,754 | — | — |
| Cash conversion cycle | 198 | 207 | 234 | 157 | 109 | 110 | 297 | 226 | 181 | 14,538 | 72 | 76 |
| Working capital days | 601 | 570 | 547 | 461 | 532 | 508 | 911 | 424 | 156 | −62 | −336 | −420 |
| ROCE % | 8.1% | 9.0% | 10.1% | 8.0% | 4.0% | 5.0% | −5.0% | −3.0% | −16.0% | −23.0% | −62.0% | −112.0% |
For the Sep 2026 quarter, Omaxe reported sales of ₹575 Cr, up 79.6% year on year and net profit of −₹26.06 Cr. The operating margin was 0.1%.
Omaxe's sales for the year to Mar 2026 were ₹1,248 Cr; over the last twelve months they were ₹1,630 Cr.
Net profit for the year to Mar 2026 was −₹699 Cr, and −₹370 Cr over the last twelve months. Earnings per share over the same trailing period were ₹−20.11.
Omaxe reported borrowings of ₹1,464 Cr at Mar 2026, against cash and equivalents of ₹906 Cr.
Cash from operations was ₹212 Cr in the year to Mar 2026; after capital spending, free cash flow was ₹185 Cr.